Endocannabinoid Signaling in the Brain

@article{Wilson2002EndocannabinoidSI,
  title={Endocannabinoid Signaling in the Brain},
  author={Rachel I. Wilson and R. Nicoll},
  journal={Science},
  year={2002},
  volume={296},
  pages={678 - 682}
}
The primary psychoactive ingredient in cannabis, Δ9-tetrahydrocannabinol (Δ9-THC), affects the brain mainly by activating a specific receptor (CB1). CB1 is expressed at high levels in many brain regions, and several endogenous brain lipids have been identified as CB1 ligands. In contrast to classical neurotransmitters, endogenous cannabinoids can function as retrograde synaptic messengers: They are released from postsynaptic neurons and travel backward across synapses, activating CB1 on… Expand
Chapter 2 – Cannabinoid Receptors and Their Signaling Mechanisms
TLDR
The present chapter discusses the current understanding of the cannabinoid receptors and their signaling cascades. Expand
The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons.
TLDR
Immunocytochemical data documenting cannabinoid CB(1) receptor expression on neurite extensions and over cell bodies of serotonergic and dopaminergic neurons is presented. Expand
Endocannabinoid Liberation from Neurons in Transsynaptic Signaling
  • D. Lovinger
  • Biology, Medicine
  • Journal of Molecular Neuroscience
  • 2007
TLDR
Significant problems remain in defining the mechanisms underlying endocannabinoid production, release, and movement across the membrane, which are discussed in the present review. Expand
Endocannabinoid System and Alcohol Abuse Disorders.
TLDR
Results are augmented by in vitro and ex vivo studies, showing that acute and chronic treatment with ethanol produces physiologically relevant alterations in the function of the eCB system during development and in the adult stage. Expand
CB1 Receptor-Mediated Signaling Mechanisms in the Deleterious Effects of Spice Abuse
TLDR
This chapter is focused on CB1R and CB2R signaling, as well as on the role ofCB1R signaling in the deleterious effects of Spice abuse. Expand
Cannabinoid Receptors and Their Relationships with Neuropsychiatric Disorders
TLDR
The endogenous cannabinoid system could play a central role in several neuropsychiatric disorders and is also involved in other conditions such as pain, spasticity and neuroprotection. Expand
The endocannabinoid system and pain.
TLDR
The roles of anandamide and 2-arachidonoylglycerol, released under physiological conditions, in modulating nociceptive responding at different levels of the neuraxis will be emphasized in this review. Expand
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids
TLDR
The involvement of the mammalian target of rapamycin pathway and extracellular signal-regulated kinases, together with their consequent regulation of cellular processes such as protein translation, play a critical role in the amnesic-like effects of cannabinoids. Expand
The molecular logic of endocannabinoid signalling
  • D. Piomelli
  • Biology, Medicine
  • Nature Reviews Neuroscience
  • 2003
The endocannabinoids are a family of lipid messengers that engage the cell surface receptors that are targeted by Δ9-tetrahydrocannabinol, the active principle in marijuana (Cannabis). They are madeExpand
CBD & D9-THC - the two faces of cannabis
TLDR
An introduction into the pharmacological and biological effects of ∆9-THC and CBD with particular reference to neurological disease is given. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 111 REFERENCES
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
TLDR
Research carried out in the past six years has confirmed a similarity between the endocannabinoids and the psychoactive substance in marijuana, delta9(-)-tetrahydrocannabinol, and suggested a role for endoc cannabinoidoids in the modulation of neurotransmitter action and release. Expand
The neurobiology and evolution of cannabinoid signalling.
  • M. Elphick, M. Egertová
  • Biology, Medicine
  • Philosophical transactions of the Royal Society of London. Series B, Biological sciences
  • 2001
TLDR
A model of cannabinoid signalling is presented in which anandamide is synthesized by postsynaptic cells and acts as a retrograde messenger molecule to modulate neurotransmitter release from presynaptic terminals, concluding that the cannabinoid signalling system may be quite restricted in its phylogenetic distribution. Expand
Molecular characterization of a peripheral receptor for cannabinoids
TLDR
The cloning of a receptor for cannabinoids is reported that is not expressed in the brain but rather in macrophages in the marginal zone of spleen, which helps clarify the non-psychoactive effects of cannabinoids. Expand
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
TLDR
The transient suppression of GABA-mediated transmission that follows depolarization of hippocampal pyramidal neurons is mediated by retrograde signalling through release of endogenous cannabinoids, indicating that the function of endogenous cannabinoid released by depolarized hippocampal neurons might be to downregulate GABA release. Expand
Presynaptic Specificity of Endocannabinoid Signaling in the Hippocampus
TLDR
It is reported that DSI is absent in mice which lack cannabinoid receptor-1 (CB1), and pharmacological and kinetic evidence suggests that CB1 activation inhibits presynaptic Ca2+ channels through direct G protein inhibition. Expand
A second endogenous cannabinoid that modulates long-term potentiation
TLDR
2-AG activates neuronal cannabinoid receptors as a full agonist, and prevents the induction of long-term potentiation at CA3–CA1 synapses, indicating that 2-AG is a second endogenous cannabinoid ligand in the central nervous system. Expand
SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice.
TLDR
Results suggest that the cannabinoid system tonically regulates thermal nociceptive thresholds and the absence of this regulation results in hyperalgesia suggesting that hypoactivity of this system may be involved in certain types of chronic pain. Expand
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.
  • K. Mackie, B. Hille
  • Chemistry, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1992
TLDR
It is found that cannabinoid receptor activation reduces the amplitude of voltage-gated calcium currents in the neuroblastoma-glioma cell line NG108-15, suggesting that inhibition of N-type calcium channels, which could decrease excitability and neurotransmitter release, may underlie some of the psychoactive effects of cannabinoids. Expand
Mechanisms of Cannabinoid Inhibition of GABAASynaptic Transmission in the Hippocampus
TLDR
Recordings of whole-cell voltage-clamp recordings suggest that presynaptic CB1 receptors reduce GABAA- but not GABAB-mediated synaptic inhibition of CA1 pyramidal neurons by inhibiting VDCCs located on inhibitory nerve terminals. Expand
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.
TLDR
Most, but not all, CNS effects of Delta9-THC are mediated by the CB1 receptor, which accounts for the abuse potential of cannabis, while other effects such as analgesia suggest potential medicinal applications. Expand
...
1
2
3
4
5
...